JuanCRamosMD

Hematology • Miami, FL

Hematologic Oncology

Professor, Medicine, University of Miami School of Medicine

Join to view full profile

Dr. Ramos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ramos' full profile

Already have an account?

Office
1475 NW 12th Ave
Fl 1
Miami, FL 33136
Phone+1 305-243-1000

Fax+1 305-243-5885
Is this information wrong?

Education & Training

University of Miami/Jackson Health SystemResidency, Internal Medicine, 1999 - 2001
Rutgers New Jersey Medical SchoolClass of 1999

Certifications & Licensure

FL State Medical License 2003 - 2025

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Clinical Trials

Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma Start of enrollment: 2008 Sep 01
Terminated
Phase 1
Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma Start of enrollment: 2007 Nov 01
Completed
Phase 1
Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma Start of enrollment: 2007 Nov 01
Terminated
Phase 4
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas Start of enrollment: 2010 Oct 06
Completed
Phase 1, Phase 2
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection Start of enrollment: 2013 Nov 01
Terminated
Phase 1
KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) Start of enrollment: 2012 Jun 01
Completed
Phase 2
Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma Start of enrollment: 2009 Apr 21
Terminated
Phase 2
Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias Start of enrollment: 2023 Nov 30
Withdrawn
Phase 1
Roles: Sponsor-Investigator, Contact, Principal Investigator
Trial of Ixazomib for Kaposi Sarcoma Start of enrollment: 2023 Nov 07
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

1 citations
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.
Lakshmi Rajdev, Chia-Ching Jackie Wang, Himanshu Joshi, Shelly Lensing, Jeannette Lee, Juan Carlos Ramos, Robert Baiocchi, Lee Ratner, Paul G Rubinstein, Richard Ambin...> ;Cancer. 2024 Mar 15
2 citations
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.
Paul G Rubinstein, Page C Moore, Milan Bimali, Jeanette Y Lee, Michelle A Rudek, Amy Chadburn, Lee Ratner, David H Henry, Ethel Cesarman, Camille E DeMarco, Dominique ...> ;The Lancet. Haematology. 2023 Aug 1
Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study.
Missak Haigentz, Page Moore, Milan Bimali, Joseph Sparano, Michelle Rudek, Lee Ratner, David Henry, Juan Ramos, John Deeken, Paul Rubinstein, Elizabeth Chiao, Timothy ...> ;The Oncologist. 2022 Aug 5
5 citations
HIV-Associated Lymphomas: Progress and New Challenges.
Georgios N Pongas, Juan C Ramos> ;Journal of Clinical Medicine. 2022 Mar 7
34 citations
Whole-genome landscape of adult T-cell leukemia/lymphoma.
Yasunori Kogure, Takuro Kameda, Junji Koya, Makoto Yoshimitsu, Kisato Nosaka, Jun-ichirou Yasunaga, Yoshitaka Imaizumi, Mizuki Watanabe, Yuki Saito, Yuta Ito, Marni B ...> ;Blood. 2021 Oct 25
3 citations
An international, multicenter, retrospective study on the positive impact of cutaneous involvement on the clinical outcome of adult T-cell leukemia/lymphoma.
Luis Malpica, Denisse Castro, Daniel J Enriquez, Roberto Oviedo-Pecho, Camila Peña, Henry Idrobo, Lorena Fiad, Maria Virginia Prates, Bryan Valcarcel, Antonio Paredes,...> ;Leukemia & Lymphoma. 2021 Sep 29
14 citations
Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de Linfoproliferativos.
Luis Malpica, Daniel J Enriquez, Denisse Castro, Camila Peña, Henry Idrobo, Lorena Fiad, Maria Virginia Prates, Victoria Otero, Mirna Biglione, Milagros Altamirano, Gu...> ;JCO Global Oncology. 2021 Jul 16
4 citations
Spotlight on ocular Kaposi's sarcoma: an update on the presentation, diagnosis, and management options.
Nandini Venkateswaran, Juan C Ramos, Adam K Cohen, Osmel P Alvarez, Noah K Cohen, Anat Galor, Carol L Karp> ;Expert Review of Ophthalmology. 2021 Jan 1
29 citations
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)
Juan Carlos Ramos, Joseph A. Sparano, Amy Chadburn, Erin Reid, Richard F. Ambinder, Eric R. Siegel, Page C. Moore, Paul G. Rubinstein, Christine M. Durand, Ethel Cesar...> ;Blood. 2020 Sep 10
Screening of human T-lymphotropic virus among solid organ transplant candidates at a large transplant center.
Jacques Simkins, Jose A. Morillas‐Rodriguez, Michele I. Morris, Lilian M. Abbo, Jose F. Camargo, Shweta Anjan, Yoichiro Natori, Warren Kupin, Phillip Ruiz, Casiana Fer...> ;Clinical Transplantation. 2020 Mar 6
8 citations
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma.
Joseph A. Sparano, Jeannette Y. Lee, Lawrence D. Kaplan, Juan Carlos Ramos, Richard F. Ambinder, William Wachsman, David M. Aboulafia, Ariela Noy, David H. Henry, Lee ...> ;Haematologica. 2020 Feb 27
6 citations
Updates in lymph node and skin pathology of adult T-cell leukemia/lymphoma, biomarkers, and beyond.
Brian D. Adkins, Juan Carlos Ramos, Meghan Bliss-Moreau, Alejandro A. Gru> ;Seminars in Diagnostic Pathology. 2020 Jan 1
45 citations
Mogamulizumab versus investigator’s choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma
Adrienne A. Phillips, Paul Fields, Olivier Hermine, Juan Carlos Ramos, Brady E Beltran, Juliana Pereira, Farooq Wandroo, Tatyana Feldman, Graham P. Taylor, Ahmed Sawas...> ;Haematologica. 2019 May 1
13 citations
Prevalence, clinical characteristics and prognosis of EBV-positive follicular lymphoma.
Nicholas Mackrides, Jennifer R. Chapman, Melissa C. Larson, Juan Carlos Ramos, Ngoc L. Toomey, Pei Lin, Matthew J. Maurer, Myra Rafaelle, Yaohong Tan, Offiong F Ikpatt...> ;American Journal of Hematology. 2019 Feb 1
137 citations
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report
Lucy Cook, Shigeo Fuji, Olivier Hermine, Ali Bazarbachi, Juan Carlos Ramos, Lee Ratner, Steve Horwitz, Paul Fields, Alina Tanase, Horia Bumbea, Kate Cwynarski, Graham ...> ;Journal of Clinical Oncology. 2019 Jan 18
7 citations
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas.
Erin Reid, David Looney, Frank Maldarelli, Ariela Noy, David H. Henry, David M. Aboulafia, Juan Carlos Ramos, Joseph A. Sparano, Richard F. Ambinder, Jeannette Y. Lee,...> ;Blood Advances. 2018 Dec 26
17 citations
Complete response to ipilimumab and nivolumab therapy in a patient with extensive extrapulmonary high-grade small cell carcinoma of the pancreas and HIV infection.
Muhammad Husnain, Wungki Park, Juan Carlos Ramos, Thomas E. Johnson, Joseph M. Chan, Arvind Dasari, Raja Mudad, Peter J. Hosein> ;Journal for Immunotherapy of Cancer. 2018 Jul 9
16 citations
CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.
Richard Hunte, Patricia Alonso, Remy Thomas, Cassandra Bazile, Juan Carlos Ramos, Louise van der Weyden, Juan Domínguez-Bendala, Wasif N. Khan, Noula Shembade> ;Plos Pathogens. 2018 Apr 26
73 citations
Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States
Luis Malpica, Agustin Pimentel, Isildinha M. Reis, Eduardo Gotuzzo, Lazaros J. Lekakis, Krishna V. Komanduri, Thomas J. Harrington, Glen N. Barber, Juan Carlos Ramos> ;Blood Advances. 2018 Mar 27
9 citations
Safety and preliminary efficacy of vorinostat with R-EPOCH in high-risk HIV-associated non-Hodgkin's lymphoma (AMC-075)
Juan Carlos Ramos, Joseph A. Sparano, Michelle A. Rudek, Page C. Moore, Ethel Cesarman, Erin Reid, David H. Henry, Lee Ratner, David M. Aboulafia, Jeanette Y. Lee, Ric...> ;Clinical Lymphoma, Myeloma & Leukemia. 2018 Mar 1
18 citations
Adult T-cell leukemia/lymphoma can be indistinguishable from other more common T-cell lymphomas. The University of Miami experience with a large cohort of cases.
Mahsa Khanlari, Juan Carlos Ramos, Sandra Sanchez, Jeong Hee Cho-Vega, Alexandra Amador, German Campuzano-Zuluaga, Francisco Vega, Jennifer R. Chapman> ;Modern Pathology. 2018 Feb 15
18 citations
Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infe...
Huseini Kagdi, Maria A Demontis, Juan Carlos Ramos, Graham P. Taylor> ;Plos Pathogens. 2018 Feb 14
57 citations
A Review of New Findings in Adult T-cell Leukemia–Lymphoma: A Focus on Current and Emerging Treatment Strategies
Olivier Hermine, Juan Carlos Ramos, Kensei Tobinai> ;Advances in Therapy. 2018 Feb 6
16 citations
Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma.
Paul G. Rubinstein, Page C. Moore, Michelle A. Rudek, David H. Henry, Juan Carlos Ramos, Lee Ratner, Erin Reid, Elad Sharon, Ariela Noy> ;AIDS. 2017 Dec 1
13 citations
Risk stratification of adult T-cell leukemia/lymphoma using immunophenotyping.
Huseini Kagdi, Maria A Demontis, Paul Fields, Juan Carlos Ramos, Charles R. M. Bangham, Graham P. Taylor> ;Cancer Medicine. 2017 Jan 1
Join now to see all

Abstracts/Posters

Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085
Juan Carlos Ramos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Identifying a Simple Clinical Prognostic Model for Aggressive Adult T-Cell Leukemia/Lymphoma in Latin American Population and Its Validation: A Large International Stu...
Juan Carlos Ramos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's Lymphoma
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019